carbamazepine vs dabigatran
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of carbamazepine and dabigatran. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Concomitant use of carbamazepine with rivaroxaban, apixaban, dabigatran, and edoxaban (direct acting oral anticoagulants) is expected to result in decreased plasma concentration of these anticoagulants that may be insufficient to achieve the intended therapeutic effect. In general, coadministration of carbamazepine with rivaroxaban, apixaban, dabigatran, and edoxaban should be avoided.
Tegretol
Pradaxa
Carbamazepine is a medicine used to control seizures and treat nerve pain. It works by reducing abnormal electrical activity in the brain and calming nerve signals.
Dabigatran (Pradaxa) is a drug that helps to prevent blood clots from forming. It is used to lower the risk of stroke and treat or prevent other dangerous clots in your body.
Carbamazepine is used to treat certain types of seizures, including partial seizures and generalized tonic-clonic seizures. It can also treat mixed seizure patterns. Carbamazepine also treats the pain from trigeminal neuralgia, a nerve disorder that causes intense facial pain. It is also sometimes used for glossopharyngeal neuralgia.
This medicine can help prevent strokes in people with an irregular heartbeat called atrial fibrillation. It can also treat blood clots in your legs (deep vein thrombosis or DVT) or lungs (pulmonary embolism or PE). Dabigatran can also lower the risk of these clots coming back. It is also used to prevent blood clots after hip replacement surgery.
Carbamazepine is an anticonvulsant. It works by reducing the spread of seizure activity in the brain. It also stabilizes nerve impulses to reduce pain.
Dabigatran is a direct thrombin inhibitor. Thrombin is a substance in the blood that helps clots form. By blocking thrombin, dabigatran helps to keep your blood from clotting too easily.
- • Dizziness
- • Drowsiness
- • Unsteadiness
- • Nausea
- • Vomiting
- • Upset stomach
- • Bleeding more easily (such as nosebleeds or heavier periods)
- Seizure 3,609
- Drug Interaction 3,369
- Fall 3,044
- Dizziness 2,862
- Pyrexia 2,689
No adverse event reports.
Carbamazepine can cause severe skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be fatal. If you are of Asian descent, you may need a blood test before starting this medicine. Carbamazepine can also cause serious blood problems like aplastic anemia and agranulocytosis. Contact your doctor right away if you develop a fever, sore throat, rash, or unusual bleeding or bruising.
Dabigatran has two important warnings. First, stopping this medicine too early can raise your risk of blood clots. Do not stop taking it without talking to your doctor. Second, this medicine can cause bleeding around the spine if you get an epidural or spinal tap. This can lead to paralysis. Tell your doctor if you are going to have any spinal procedures.
Carbamazepine may harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if carbamazepine passes into breast milk, so talk to your doctor about breastfeeding.
Talk to your doctor if you are pregnant or plan to become pregnant. Dabigatran may increase the risk of bleeding in the fetus. Breastfeeding is not recommended while taking this medicine.
Also Compare, Nearby Drugs
Compare carbamazepine with
How to Read This carbamazepine vs dabigatran Comparison
carbamazepine is classified in the Anticonvulsant drug class, while dabigatran sits within the Direct Thrombin Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, carbamazepine has 15,573 submissions while dabigatran has 0. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to carbamazepine makes your body process dabigatran faster, which can lower the amount of medicine in your blood.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for carbamazepine or dabigatran.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.